Menzel Garry E
CIK: 0001556064
Director
Primary company: TCR2 THERAPEUTICS INC. (TCRR)
Menzel Garry E is a corporate insider at TCR2 THERAPEUTICS INC. (TCRR) filing SEC Form 4 transactions. 85 transactions across 6 companies, totaling $0 in purchases and $145,312 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 40,000 | $1.71 | $68K | 40,000 | 6/26/2026 Filed: 6/26/2026 | Filing → | |
| Award | 30,550 | - | - | 30,550 | 6/12/2025 Filed: 6/12/2025 | Filing → | |
| Award | 29,747 | - | - | 29,747 | 6/3/2025 Filed: 6/4/2025 | Filing → | |
Adaptimmune Therapeutics PLC ADAP | Award | 1,121,604 | - | - | 1,121,604 | 7/1/2024 Filed: 7/1/2024 | Filing → |
| Award | 7,639 | - | - | 7,639 | 6/5/2024 Filed: 6/7/2024 | Filing → | |
| Award | 30,550 | - | - | 30,550 | 6/6/2024 Filed: 6/6/2024 | Filing → | |
Adaptimmune Therapeutics PLC ADAP | Sale | 47,702 | $0.91 | $43K | 75,056 | 7/10/2023 Filed: 7/10/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 2,158,776 | $0.00 | $0 | 2,158,776 | 7/5/2023 Filed: 7/5/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 2,715,816 | $0.00 | $0 | 2,715,816 | 7/5/2023 Filed: 7/5/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 57,846 | $0.00 | $0 | 57,846 | 7/5/2023 Filed: 7/5/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 3,568,026 | $0.00 | $0 | 3,568,026 | 7/5/2023 Filed: 7/5/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 359,700 | $0.00 | $0 | 359,700 | 7/5/2023 Filed: 7/5/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 1,251,966 | $0.00 | $0 | 1,251,966 | 7/5/2023 Filed: 7/5/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 736,548 | $0.00 | $0 | 736,548 | 7/5/2023 Filed: 7/5/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 981,463 | $0.00 | $0 | 981,463 | 7/3/2023 Filed: 7/3/2023 | Filing → |
| Award | 19,441 | $0.00 | $0 | 19,441 | 6/13/2023 Filed: 6/15/2023 | Filing → | |
Adaptimmune Therapeutics PLC ADAP | Award | 209,931 | - | - | 209,931 | 6/1/2023 Filed: 6/1/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 200,647 | - | - | 200,647 | 6/1/2023 Filed: 6/1/2023 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 200,646 | - | - | 200,646 | 6/1/2023 Filed: 6/1/2023 | Filing → |
TCR2 THERAPEUTICS INC. TCRR | Disposition | 39,681 | $0.00 | $0 | 0 | 6/1/2023 Filed: 6/1/2023 | Filing → |
Type
Award
Shares
40,000
Price
$1.71
Value
$68K
Type
Award
Shares
30,550
Price
-
Value
-
Type
Award
Shares
29,747
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
1,121,604
Price
-
Value
-
Type
Award
Shares
7,639
Price
-
Value
-
Type
Award
Shares
30,550
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
47,702
Price
$0.91
Value
$43K
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
2,158,776
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
2,715,816
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
57,846
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
3,568,026
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
359,700
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
1,251,966
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
736,548
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
981,463
Price
$0.00
Value
$0
Type
Award
Shares
19,441
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
209,931
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
200,647
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
200,646
Price
-
Value
-
TCR2 THERAPEUTICS INC.
TCRR
Type
Disposition
Shares
39,681
Price
$0.00
Value
$0
AI Agent
Try asking...